已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Landscape of C-MET overexpression in non-small cell lung cancer: a large-scale study of clinicomolecular features and prognosis based on Chinese data

医学 免疫组织化学 间变性淋巴瘤激酶 克拉斯 肺癌 内科学 肿瘤科 阶段(地层学) 腺癌 人口 克里唑蒂尼 ROS1型 癌症 癌症研究 病理 生物 古生物学 结直肠癌 恶性胸腔积液 环境卫生
作者
Shuting Zhan,Jianfu Li,Bo Cheng,Caichen Li,Yi Feng,Lei Fan,Shan Xiong,Wenchuang Zeng,Qi Cai,Yang Xiang,Huiting Wang,Chunyan Li,Peiling Chen,Xin Zheng,Wenhai Fu,Zhexue Hao,Jianxing He,Wenhua Liang
出处
期刊:Therapeutic Advances in Medical Oncology [SAGE Publishing]
卷期号:16: 17588359241279715-17588359241279715 被引量:13
标识
DOI:10.1177/17588359241279715
摘要

Background: Real-world data on C-MET protein overexpression in non-small cell lung cancer (NSCLC) patients, particularly among the Asian Chinese population, are limited. Objectives: This study aimed to evaluate the clinicomolecular characteristics and prognosis of C-MET overexpression in Chinese NSCLC patients, focusing on those with positive C-MET overexpression (immunohistochemistry (IHC) 3+). Design: A retrospective and observational study. Methods: Data were collected from NSCLC patients diagnosed at the First Affiliated Hospital of Guangzhou Medical University between November 2006 and April 2021. We identified C-MET overexpression using IHC and C-MET overexpression positivity was defined as IHC 3+ with ⩾50% tumor cells. Additionally, patient genotypes were collected for subgroup analysis. Results: Data from 9785 NSCLC patients were collected. C-MET (−) accounted for 5% (503/9785), C-MET (+) for 27% (2654/9785), C-MET (++) for 36% (3464/9785), and C-MET (+++) for 32% (3164/9785). Genetic testing was available for 4326 patients. Wild-type was observed in 37% (1591 cases), with epidermal growth factor receptor ( EGFR) abnormalities being the most common at 49% (2127 cases). Positive C-MET overexpression correlated significantly with women ( p < 0.001), early-stage ( p = 0.003), adenocarcinoma ( p < 0.001), and driver mutations ( p < 0.001). Patients with anaplastic lymphoma kinase ( ALK) alterations had a higher occurrence of C-MET overexpression positivity (57.1%). Positive C-MET overexpression was significantly associated with EGFR ( p < 0.001), ALK ( p < 0.001), and KRAS alterations ( p = 0.024). Compared to C-MET overexpression (IHC 0), C-MET overexpression (IHC 2+) (hazard ratio (HR) = 0.455, p < 0.001) and C-MET overexpression (IHC 3+) (HR = 0.569, p < 0.001) were correlated with better overall survival in overall NSCLC patients, especially for C-MET overexpression (IHC 2+). Conclusion: Our study elucidates the clinicomolecular characteristics and prognosis of C-MET overexpression in NSCLC patients, particularly those with positive C-MET overexpression (IHC 3+). This provides insight into the prevalence of C-MET overexpression in Chinese NSCLC patients and offers a basis for considering C-MET overexpression as a prognostic and predictive marker in NSCLC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
余香的应助被第四周期采纳,获得10
2秒前
老实惜海完成签到,获得积分10
2秒前
情怀的应助被tejing1158采纳,获得10
2秒前
小蘑菇的应助被richardhipower采纳,获得10
4秒前
kelaibing发布了新的文献求助10
4秒前
所所的应助被歪歪采纳,获得10
4秒前
mofudyc发布了新的文献求助10
5秒前
qingqingdandan完成签到 ,获得积分10
6秒前
6秒前
7秒前
sln完成签到,获得积分20
9秒前
阿南发布了新的文献求助10
10秒前
科目三的应助被tejing1158采纳,获得10
11秒前
巴斯光年发布了新的文献求助10
11秒前
11秒前
慕青的应助被xc采纳,获得10
11秒前
13秒前
东东完成签到 ,获得积分10
16秒前
xiaoyu完成签到,获得积分10
16秒前
17秒前
草根努力记完成签到 ,获得积分10
18秒前
Aspire完成签到 ,获得积分10
18秒前
xx发布了新的文献求助10
19秒前
20秒前
kelaibing完成签到,获得积分10
20秒前
Yao完成签到,获得积分10
20秒前
烟花的应助被tejing1158采纳,获得10
21秒前
wzx发布了新的文献求助10
21秒前
魏子合完成签到 ,获得积分10
22秒前
巴斯光年完成签到,获得积分20
23秒前
阿南发布了新的文献求助10
23秒前
gghjgjkgui完成签到,获得积分10
24秒前
田様的应助被Postgraduate-Z采纳,获得10
24秒前
ifast完成签到 ,获得积分10
26秒前
上官若男的应助被xc采纳,获得10
26秒前
天天快乐的应助被mofudyc采纳,获得10
27秒前
27秒前
28秒前
核桃发布了新的文献求助10
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189722
求助须知:如何正确求助?哪些是违规求助? 9576968
关于积分的说明 21850614
捐赠科研通 7787686
什么是DOI,文献DOI怎么找? 3435771
关于科研通互助平台的介绍 2559813
邀请新用户注册赠送积分活动 2482639